Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients

Medicine and Dentistry

• Hallucination 100%
• Patient 58%
• Parkinson's Disease 50%
• Surgery 25%
• Unified Parkinson's Disease Rating Scale 25%
• Stimulation 16%
• Deterioration 16%
• Subthalamic Nucleus 16%
• Thought Disorder 16%
• Development 8%
• Drug 8%
• Combination Therapy 8%
• Chemotherapeutic Agent 8%
• Pathogenesis 8%
• Diseases 8%
• McNemar Test 8%
• Equivalent Dose 8%
• Contraindication 8%
• Levodopa 8%
• Antiparkinson Agent 8%
• Symptom 8%

Psychology

• Hallucinations 100%
• Thought Disorder 16%
• Treatment 8%
• Interviews 8%
• Rating Scale 8%